Clinical Trials
34 trialsBiospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
National Institutes of Health Clinical Center (CC)
Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones
National Cancer Institute (NCI)
Evaluation of Broccoli Seed and Sprout Extract for Detoxification of Carcinogens in Firefighters
National Cancer Institute (NCI)
Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma
National Cancer Institute (NCI)
Collection of Blood, Bone Marrow, Tumor or Tissue Samples
National Institutes of Health Clinical Center (CC)
Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer
National Cancer Institute (NCI)
Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced Cancer
National Cancer Institute (NCI)
Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia
National Cancer Institute (NCI)
Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas
National Cancer Institute (NCI)
Effect of Solar-Simulated Ultraviolet Radiation on Gene Expression in Unprotected and Sunscreen-Protected Skin of Healthy Adults With Fitzpatrick Skin Type II
National Cancer Institute (NCI)
Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps
National Cancer Institute (NCI)
Lovastatin in Treating Patients At High Risk of Melanoma
National Cancer Institute (NCI)
Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia
National Cancer Institute (NCI)
Tethered Capsule Endoscope in Screening Participants for Barrett Esophagus
National Cancer Institute (NCI)
Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer
National Cancer Institute (NCI)
Improving the Frequency of Colonoscopy in Patients With a Previous Colorectal Polyp
National Cancer Institute (NCI)
Beta Alethine in Treating Patients With Myeloma
National Cancer Institute (NCI)
T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum
National Cancer Institute (NCI)
SGN-00101 in Treating Patients With Cervical Intraepithelial Neoplasia
National Cancer Institute (NCI)
Erlotinib in Treating Patients With Barrett Esophagus
National Cancer Institute (NCI)
Studying Genes for Barrett's Esophagus in Brothers and Sisters
National Cancer Institute (NCI)
Aspirin Mouthwash in Treating Patients With Oral Leukoplakia
National Cancer Institute (NCI)
Diindolylmethane in Treating Patients With Abnormal Cervical Cells
National Cancer Institute (NCI)
Self-Sampling in Women Who Do Not Undergo Routine Cervical Screening
National Cancer Institute (NCI)
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
National Cancer Institute (NCI)
Decitabine in Treating Patients With Melanoma or Other Advanced Cancer
National Cancer Institute (NCI)
Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer
National Cancer Institute (NCI)
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis
National Institutes of Health Clinical Center (CC)
Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx
National Cancer Institute (NCI)
Study of Pap Smears From Patients Enrolled on Clinical Trial GOG-171
National Cancer Institute (NCI)
Inositol in Preventing Lung Cancer in Patients With Bronchial Epithelial Dysplasia Who Are Current or Former Smokers
National Cancer Institute (NCI)
Spectroscopy in Diagnosing Dysplasia and Neoplasia in the Cervix in Women Undergoing Colposcopy
National Cancer Institute (NCI)
Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders
National Cancer Institute (NCI)
Cidofovir in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Who Are Receiving Chemotherapy and Radiation Therapy
National Cancer Institute (NCI)